In the Original Investigation titled “Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial,”1 published online May 2, 2018, the points indicating intravitreal aflibercept injection plus sham photodynamic therapy and intravitreal aflibercept injection plus active photodynamic therapy in panel A of Figure 2 were transposed. This article was corrected online.
Reference
- 1.Lee WK, Iida T, Ogura Y, et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial [published online May 2, 2018]. JAMA Ophthalmol. doi: 10.1001/jamaophthalmol.2018.1804 [DOI] [PMC free article] [PubMed] [Google Scholar]